-
Raul Fernandez wins British MotoGP Grand Prix
-
London grants first licences for supervised Uber robotaxis
-
Tesla FSD secrecy puts Europe’s safety oversight under scrutiny
-
Erasmus hopeful Kolisi hamstring injury not 'too bad'
-
Mercedes-AMG GT 53 balances speed, range and daily usability
-
Luxury car buyers trade prestige for mainstream value
-
Lion queen Werro focused on Euro medal, not 800m world record
-
Students, teachers mourn girl killed in Thailand school shooting
-
Changan uses FILDA 2026 to accelerate its African expansion
-
Jacobson to lead New Zealand for first time against Sharks
-
Honda plots a profitable European comeback without a price war
-
Typhoon Dolphin makes landfall in China after flight cancellations, evacuations
-
Iran Guards say won't reopen Hormuz without US meeting all Tehran's conditions
-
South Korea FA apologises after sex scandal adds to controversies
-
Messi absent after father's death as Miami lose in Leagues Cup
-
Indonesia closes national park as wildfire spreads
-
Flight cancellations, evacuations in China as Typhoon Dolphin looms
-
ZXMoto leads China's charge to dominate the global motorbike market
-
Iran issues demands for reopening of Hormuz
-
Top-ranked Sabalenka, Pegula stunned in Toronto fourth round
-
Afghanistan's gold rush upends lives and landscapes
-
Japan nuclear debate unnerves proponents of pacifism
-
Messi missing after father's death as Miami lose in Leagues Cup
-
Spanish teen Jodar ousts eighth seed Lehecka at Montreal
-
World number one Sabalenka ousted in Toronto by Alexandrova
-
Angers mounts in US over vast network of car license plate cams
-
Olympic weightlifter hoists debris for Venezuela earthquake recovery
-
Darderi to face Nakashima in Montreal quarter-finals
-
FIFA condemns 'concerted and ongoing effort' to weaken Infantino
-
Espresso power fires Darderi past Borges in Montreal
-
South Africa win after surviving late Argentina surge
-
Shnaider upsets Pegula to book Toronto quarter-final with Swiatek
-
Man Utd boss Carrick being 'careful' with Mount as Man Utd draw with PSG
-
Mount injury overshadows Man Utd draw with Paris Saint-Germain
-
All Black Tuipulotu surprised after Sharks include Nonu
-
Ukraine denies targeting Bulgaria as drone explodes near pipeline
-
Infantino denies allegations of affair, favouritism while at UEFA: report
-
Vollering grabs Tour de France lead in Nice
-
MotoGP leader Martin soars to victory in British GP sprint race
-
Euros to showcase new TV guidelines on non-sexualisation of women athletes
-
Mosimane set to succeed Broos as South Africa coach
-
'Calm' Kiss savours first win as Wallabies boss
-
Drone enters Bulgaria, explodes near pipeline at Romanian border
-
Duplantis bids for fourth European title as stars align in Birmingham
-
Paris orders e-scooter users to wear helmets, reflective gear
-
Ukraine warns of tough winter as Russia strikes kill 4 in Kyiv region
-
Lionel Messi's father Jorge dies aged 68
-
Recovering Marchand to skip medleys at European swim champs
Monsanto: object of Bayer desire despite GMO fears
German pharmaceutical giant Bayer sees in agroindustry giant Monsanto a gem worth at least $62 million for its dominant global position selling seeds sought by farmers of corn, soybeans, cotton and other commodity crops.
But for the Green movement, especially in Europe, Monsanto turns stomachs for unstinting promotion of genetically modified crops and its widely used herbicide Roundup, often feared as a possible carcinogen.
The merger is still under discussion -- Monsanto rejected the price as too low on Tuesday, but said it is willing to keep talking.
But it raises questions across an industry that is pushing the frontiers of biochemistry amid great nervousness, and consolidating into just a handful of very powerful firms.
- What is Monsanto? -
St. Louis, Missouri-based Monsanto was established by pharmacist John Queeny in 1901 to produce saccharine. Queeny named the company after his wife Olga Monsanto Queeny.
By the 1940s, the company was producing farm-oriented chemicals, particularly the widely used herbicide 2,4-D, and slowly became a US household name.
Combined with another dangerous chemical, 2,4-D was used to make the notorious Vietnam War-era defoliant Agent Orange.
In 1976, it launched probably its most famous product, Roundup, the world's most widely used herbicide. Its active chemical is glyphosate.
The company began in the 1970s looking at the crops that the herbicides were protected, building cell and molecular biology units. In 1982, its scientists were the first to genetically modify a plant cell.
Monsanto then started buying other seed companies and withing five years began field trials of genetically modified seeds.
It eventually developed soybean, corn, cotton, canola and other crops that were genetically engineered to be tolerant of Roundup.
In 1994, Monsanto also became the first to begin selling the biotechnology-based hormone for dairy cows, rBST and rBGH, which was used across the United States to boost milk production. The two have been banned by many other major dairy producers.
- Why is Monsanto so valuable to Bayer? -
Monsanto is by far the world's leading producer of genetically modified crop seeds, and in many of its seed lines it has a dominant market position.
According to Farm Journal, it had 35.5 percent of the market for corn in the United States in 2014. It had a 28 percent share for soybeans, behind DuPont.
The company owns around 1,700 patents. In 1991, it lost its patent on glyphosate herbicide, but retains a huge market share in part by having marketed its "Roundup-Ready" genetically modified seeds.
Monsanto also owns one of the leading data analytics firms for farmers, Climate Corp.
- What makes Monsanto so controversial? -
Many people and countries, especially in Europe, have not accepted the use of genetically modified organisms -- which they label "frankenfoods."
They say GMO seeds are dangerous to introduce to the farm and food system generally, and foods produced from GMO crops could turn out unsafe to eat.
In addition, Monsanto's strong market position, critics say, can leave farmers dependent on it because they cannot reproduce Monsanto crops with their own seeds due to the company's patents.
In addition, critics say the herbicides the company sells are dangerous to human health, and some have been banned in certain countries.
A merger with Bayer thus could give the combined company even more power in the market, with farmers already facing consolidation among suppliers.
In December, DuPont and Dow Chemical announce plans to merge, and in China National Chemical Corp. or ChemChina, made a $43 billion offer for Syngenta.
M.Odermatt--BTB